April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
24 Months Follow Up Evaluation Of Pars Plana Clip Ahmed-Valve Implant Surgery
Author Affiliations & Notes
  • Hendrik Schwarzer
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Babac A. Mazinani
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Gernot F. Roessler
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Niklas Plange
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Peter Walter
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Footnotes
    Commercial Relationships  Hendrik Schwarzer, None; Babac A. Mazinani, None; Gernot F. Roessler, None; Niklas Plange, None; Peter Walter, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 541. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hendrik Schwarzer, Babac A. Mazinani, Gernot F. Roessler, Niklas Plange, Peter Walter; 24 Months Follow Up Evaluation Of Pars Plana Clip Ahmed-Valve Implant Surgery. Invest. Ophthalmol. Vis. Sci. 2011;52(14):541.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the efficiency, stability and safety of pars plana clip Ahmed-Valve implant surgery in therapy refractive secondary glaucoma patients.

Methods: : 22 patients and a total of 27 eyes were included in this retrospective study, all of which underwent a pars plana vitrecomy and a pars plana administrated Ahmed-valve implant due to therapy refractive secondary glaucoma. The collective of patients consisted of 21 female and 1 male patient. The age varied between 27 and 81 years at the time of surgery. The IOP, visual acuity and number of applied pharmaceutical active topical agents were monitored at the time of indication of the surgery as well as 1, 3, 6, 12 and 24 months post-operatively. The incidence of post-operative complications, particularly tenon cysts with accompanied IOP re-raise was also investigated and monitored for 24 months after revision.

Results: : The mean IOP at the time of indication of the surgery was 30.2 ± 4.2mmHg and the mean number of topical agents applied was 2.8 ± 0.6. 12 months after surgery the IOP was 14.3 ± 3.0mmHg and the number of topical agents 1.2 ± 0.6. 24 months after surgery the IOP was 13.9 ± 3.1mmHg and the number of topical agents 1.2 ± 0.6. The IOP lowering effect was highly significant after 12 and 24 months (p<0.001). The difference between 12 and 24 months was no longer significant (p=0.33). The mean visual acuity was 20/200 before the surgery and remained stable after 24 months (20/100). The most frequent complication was a tenon cyst that appeared in 12 of 27 eyes. The mean occurrence of this IOP-raising tenon cyst was after 3.7 ± 1.8 months but all occurred before 8 months. At the time of a cyst revision the mean IOP was 27.3 ± 2.7mmHg. 12 months after revision of the tenon cyst the mean IOP was 14.5 ± 2.0mmHg. Other complications included endophthalmitis (n=1), retinal detachment (n=2), persistent hypotonia (n=2).

Conclusions: : Pars plana clip Ahmed-valve implant surgery is efficient in highly complicated secondary glaucomatous eyes. Visual acuity and IOP levels can be controlled and stabilized permanently. However, one has to take into account that there are some minor and some severe post-operative complications that might make further operations necessary.

Keywords: vitreoretinal surgery • intraocular pressure • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×